A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Gout

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Amicis Research Center, Granada Hills, California, United States

    Contact: Study coordinator (Pascal Dabel, MD)
  • Cohen Medical Center, Thousand Oaks, California, United States

    Contact: Study coordinator (Shariar Cohen-Gadol, MD)
  • Omega Research Group, DeBary, Florida, United States

    Contact: Study coordinator (Kwabena Ayesu, MD)
  • Clinical Research of Central Florida, Lakeland, Florida, United States

    Contact: Study coordinator (Michael Gimness, MD)
  • Panax Clinical Research, Miami, Florida, United States

    Contact: Study coordinator (Robert Perry, MD)
  • Anchor Medical Research, Miami, Florida, United States

    Contact: Study coordinator (Juvenal Martinez, MD)
  • MD Medical Research, Oxon Hill, Maryland, United States

    Contact: Study coordinator (Stephen Ong, MD)
  • Clinical Research Institute of Michigan, Saint Clair Shores, Michigan, United States

    Contact: Study coordinator (Amar Majjhoo, MD)
  • Revival Research Institute, Sterling Heights, Michigan, United States

    Contact: Study coordinator (Syed Husain, MD)
  • Las Vegas Clinical Trials, Las Vegas, Nevada, United States

    Contact: Study coordinator (Alton Walters, MD)
  • Ellipsis Research Group, Brooklyn, New York, United States

    Contact: Study coordinator (Jorge Serje, MD)
  • Drug Trials America, Hartsdale, New York, United States

    Contact: Study coordinator (Michael Gerdis, MD)
  • Shelby Clinical Research, Shelby, North Carolina, United States

    Contact: Study coordinator (Christian Martin, MD)
  • Zenos Clinical Research, Dallas, Texas, United States

    Contact: Study coordinator (Bachar Elsaadi, MD)
  • Epic Medical Research, DeSoto, Texas, United States

    Contact: Study coordinator (Haresh Boghara, MD)
  • Pioneer Research Solutions, Houston, Texas, United States

    Contact: Study coordinator (Francisco Velazquez, MD)
  • DM Clinical Research, Tomball, Texas, United States

    Contact: Study coordinator (Shaikh Ali, MD)